These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36036300)

  • 1. Local and Global Abnormalities in Pre-symptomatic Huntington's Disease Revealed by 7T Resting-state Functional MRI.
    Xie JJ; Li XY; Dong Y; Chen C; Qu BY; Wang S; Xu H; Roe AW; Lai HY; Wu ZY
    Neurosci Bull; 2023 Jan; 39(1):94-98. PubMed ID: 36036300
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional MRI signal fluctuations highlight altered resting brain activity in Huntington's disease.
    Sarappa C; Salvatore E; Filla A; Cocozza S; Russo CV; Saccà F; Brunetti A; De Michele G; Quarantelli M
    Brain Imaging Behav; 2017 Oct; 11(5):1459-1469. PubMed ID: 27734308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network topology and functional connectivity disturbances precede the onset of Huntington's disease.
    Harrington DL; Rubinov M; Durgerian S; Mourany L; Reece C; Koenig K; Bullmore E; Long JD; Paulsen JS; ; Rao SM
    Brain; 2015 Aug; 138(Pt 8):2332-46. PubMed ID: 26059655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and Dynamics of Large-Scale Cognitive Networks in Huntington's Disease.
    Aracil-Bolaños I; Martínez-Horta S; González-de-Echávarri JM; Sampedro F; Pérez-Pérez J; Horta-Barba A; Campolongo A; Izquierdo C; Gómez-Ansón B; Pagonabarraga J; Kulisevsky J
    Mov Disord; 2022 Feb; 37(2):343-353. PubMed ID: 34752656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease: Brain imaging in Huntington's disease.
    Johnson EB; Gregory S
    Prog Mol Biol Transl Sci; 2019; 165():321-369. PubMed ID: 31481169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting-state fMRI reveals longitudinal alterations in brain network connectivity in the zQ175DN mouse model of Huntington's disease.
    Vasilkovska T; Adhikari MH; Van Audekerke J; Salajeghe S; Pustina D; Cachope R; Tang H; Liu L; Muñoz-Sanjuán I; Van der Linden A; Verhoye M
    Neurobiol Dis; 2023 Jun; 181():106095. PubMed ID: 36963694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease.
    Yao J; Morrison MA; Jakary A; Avadiappan S; Chen Y; Luitjens J; Glueck J; Driscoll T; Geschwind MD; Nelson AB; Villanueva-Meyer JE; Hess CP; Lupo JM
    Neuroimage; 2023 Jan; 265():119788. PubMed ID: 36476567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging in Huntington's Disease.
    Gregory S; Scahill RI; Rees G; Tabrizi S
    Methods Mol Biol; 2018; 1780():303-328. PubMed ID: 29856026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive spinal cord atrophy in manifest and premanifest Huntington's disease.
    Wilhelms W; Bellenberg B; Köster O; Weiler F; Hoffmann R; Gold R; Saft C; Lukas C
    J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):614-616. PubMed ID: 28209652
    [No Abstract]   [Full Text] [Related]  

  • 10. An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease.
    Garcia-Gorro C; Garau-Rolandi M; Escrichs A; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; de Diego-Balaguer R; Camara E
    Neuropsychologia; 2019 Jan; 122():116-124. PubMed ID: 30563619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.
    Steventon JJ; Trueman RC; Ma D; Yhnell E; Bayram-Weston Z; Modat M; Cardoso J; Ourselin S; Lythgoe M; Stewart A; Rosser AE; Jones DK
    Sci Rep; 2016 Sep; 6():32423. PubMed ID: 27581950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation in Huntington's Disease: New Insights with
    Lois C; González I; Izquierdo-García D; Zürcher NR; Wilkens P; Loggia ML; Hooker JM; Rosas HD
    ACS Chem Neurosci; 2018 Nov; 9(11):2563-2571. PubMed ID: 29719953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic functional network connectivity in Huntington's disease and its associations with motor and cognitive measures.
    Espinoza FA; Liu J; Ciarochi J; Turner JA; Vergara VM; Caprihan A; Misiura M; Johnson HJ; Long JD; Bockholt JH; Paulsen JS; Calhoun VD
    Hum Brain Mapp; 2019 Apr; 40(6):1955-1968. PubMed ID: 30618191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
    Gargouri F; Messé A; Perlbarg V; Valabregue R; McColgan P; Yahia-Cherif L; Fernandez-Vidal S; Ben Hamida A; Benali H; Tabrizi S; Durr A; Lehéricy S
    Hum Brain Mapp; 2016 Nov; 37(11):4112-4128. PubMed ID: 27400836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Magnetic Resonance Imaging in Huntington's Disease.
    Gregory S; Scahill RI
    Int Rev Neurobiol; 2018; 142():381-408. PubMed ID: 30409260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
    Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington's disease.
    van de Zande NA; Bulk M; Najac C; van der Weerd L; de Bresser J; Lewerenz J; Ronen I; de Bot ST
    Neuroimage Clin; 2023; 39():103450. PubMed ID: 37327706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging in Huntington's disease.
    Paulsen JS
    Exp Neurol; 2009 Apr; 216(2):272-7. PubMed ID: 19171138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: The IMAGE-HD study.
    Ahveninen LM; Stout JC; Georgiou-Karistianis N; Lorenzetti V; Glikmann-Johnston Y
    Neuroimage Clin; 2018; 18():881-887. PubMed ID: 29876272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET.
    Andrews TC; Brooks DJ
    Mol Med Today; 1998 Dec; 4(12):532-9. PubMed ID: 9866823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.